UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
UBS Bumps PT on Mylan (MYL) to $33; Agila Deal a Good Way to Start 2013
-
UBS Maintains a 'Buy' on Mylan (MYL); Don't Underestimate the EpiPen
-
UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap
-
UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock
-
UBS Maintains a 'Buy' on Teva Pharma (TEVA); The Decision's In
-
UBS on U.S. Pharma - Large Cap and Specialty: Q1 Preview - Off to a Good Start
-
Notable Analyst Rating Changes 03/15: (AMD) (UNP) (LVLT) Upgraded; (EBAY) (LAZ) (WMS) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 03/02: (BAC) (RAD) (ZNGA) (MWW) (MYL) (DKS)
-
UBS on U.S. Pharma – Large Cap and Specialty: 4Q11 Preview: Things Still Look Interesting
-
Notable Analyst Rating Changes 09/28: (BMRN) (LEAP) (MAS) Upgraded; (BZ) (BPO) (KMB) Downgraded
-
Notable Analyst Rating Changes 09/22: (NFLX) (INTC) (YHOO) Upgraded; (JNJ) (ZMH) (PG) Downgraded
-
Notable Analyst Rating Changes 05/04: (FSLR) (SNY) (FE) Upgraded; (MEE) (NSC) (MYL) Downgraded
-
UBS Maintains a 'Buy' on Mylan (MYL); Lipitor/Caduet Fuels Upward Momentum
-
Daily State of the Markets 09/23: Shoulda, Coulda, Woulda?
-
Notable Analyst Rating Changes 09/23: EW, MYL, NVDA, ENDP Upgraded; DYN, MO, OXPS, CVVT Downgraded
-
Notable Analyst Rating Changes 08/09: SKH, MYL, BEE, PG Upgraded; PCS, MDT, PMC, CSA Downgraded
-
Mylan (MYL) Subsidiary Launches Temazepam Capsules USP, 7.5 mg
-
Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
-
Trading Radar for 7/30: ExxonMobil (XOM), Disney (DIS), Dow (DOW), Motorola (MOT), Las Vegas Sands (LVS), MasterCard (MA), First Solar (FSLR), Sony (SNE), MetLife (MET), Wynn (WYNN) Report
-
Unusual 11 Mid-Day Movers 7/27: ACAD, ARIA, UQM, HNBC Higher; RPRX, MYL, CALM, SNDA Lower
-
David Moenning's Daily State of the Markets: 5/14
-
David Moenning's Daily State of the Markets: 4/30
-
David Moenning's Daily State of the Markets: 3/13
-
UBS Initiates Coverage on Several Drug Manufacturers
-
Mylan (MYL) CEO Buys Another 10K Shares; Has Bought 50K Shares Over Past Few Days
-
David Moenning's Daily State of the Markets 2/23
-
Notable Analyst Rating Changes 1/21: F, UL, RYAAY, JBL Upgraded; WMT, AA, WFR, FRX Downgraded
-
David Moenning's Daily State of the Markets: 1/07
-
David Moenning's Daily State of the Markets: 8/06
-
Buckingham Research Upgrades Mylan (MYL) to Strong Buy
-
After-Hours Movers 2/27: DBRN, NKTR, CRM Higher on Earnings, AAPL Up on iPhone Sales; SEED, MYL Lower on Earnings
-
David Moenning's Daily State of the Markets: 2/7
-
Unusual 11 Mid-Day Movers 12/31: JADE, TMY, DSTI Higher; CHC, SLXP, COGT Lower
